US OptionsDetailed Quotes
NVAX250502P8500
- 1.46
- +0.07+5.04%
15min DelayTrading Apr 28 09:40 ET
1.46High1.46Low
1.46Open1.39Pre Close2 Volume2 Open Interest8.50Strike Price292.00Turnover123.37%IV-4.68%PremiumMay 2, 2025Expiry Date1.78Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9625Delta0.0994Gamma3.72Leverage Ratio-0.0067Theta-0.0006Rho-3.58Eff Leverage0.0006Vega
Novavax Stock Discussion
Novavax () issued the following update on the U.S. FDA BLA for Novavax’s COVID-19 Vaccine: “Last week, Novavax responded to the formal communication received from the U.S. Food and Drug Administration for our Biologics License Application (BLA) and our response addresses the request for a postmarketing commitment for a clinical trial. PMCs by their nature are completed after BLA approval. PMCs are not unusual with many approved drugs and/or biologics having at least one PMC or...
Good loading level.
Full FDA Approval: 10-30
Pandemic: 150-250
Whoever decided to sell at 7+ dollars, you are either crazy or just here for trade with quick profit. This ain’t some penny stock we are talking about. Hold well and you will be rewarded handsomely.
The $Nasdaq Composite Index (.IXIC.US)$ led the way higher, gaining 407.63 (2.5%) to 16,708.05, while the $S&P 500 Index (.SPX.US)$ added 88.10 ticks (1.7%) to 5,375.86.
Similarly, the $Dow Jones Industrial Average (.DJI.US)$ rose 419....
as a long term investor, this is nothing compare to the official approval, and the jackpot, next pandemic.
Novavax: "We Believe That Our Bla Is Approvable Based on Conversations With FDA, as of Our Pdufa Date on April 1 and Through Today
No comment yet